Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Enrollment begins in new clinical trials of 7-day combination contraceptive patch

Aug. 14, 2001

Compounds useful as cell adhesion inhibitors patented by Aventis and Genentech

Aug. 13, 2001

Kyoto Pharmaceutical reports new derivatives with glucose- and triglyceride-lowering activity

Aug. 10, 2001

Preliminary animal studies indicate that Oxycyte may be safer than other PFC emulsions

Aug. 10, 2001

Dual PPAR agonist shows good preclinical results

Aug. 10, 2001

Sustained-release preparations of hypoglycemic drugs described by Ajinomoto

Aug. 9, 2001

Bayer withdraws cerivastatin worldwide

Aug. 9, 2001

Data from Metformin GR phase II trial reported by DepoMed

Aug. 9, 2001

Replagal receives European approval for Fabry's disease

Aug. 9, 2001

Taisho patents compounds for treating bone or neurological diseases

Aug. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...